Intravitreal ranibizumab as an adjunctive treatment for coats disease (6-year follow-up)

Discussion: Elevated vascular endothelial growth factor levels have been demonstrated in Coats disease. Anti–vascular endothelial growth factor agents assist to the decrease of vascular permeability of the capillary endothelial cells, thus increasing the efficiency of laser application.
Source: Retinal Cases and Brief Reports - Category: Opthalmology Tags: Case Report Source Type: research